Form 4: Teladoc Health Executive Adam C. Vandervoort Reports Stock Transactions
SEC Form 4
Adam C. Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, reports the acquisition and disposal of common stock and derivative securities.
Summary
- On August 30, 2024, Adam C. Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, exercised performance stock units and restricted stock units, converting them into common stock.
- He acquired 1,505 shares, 1,881 shares, and 4,417 shares through these conversions.
- On September 3, 2024, Vandervoort sold 2,817 shares of common stock at a price of $7.164 per share.
- Following these transactions, Vandervoort directly owns 46,250 shares of Teladoc Health common stock.
- He also holds 9,035 Performance Stock Units, 3,762 Restricted Stock Units, and 26,508 Restricted Stock Units.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common practice for publicly traded companies. It provides transparency into the trading activities of key personnel.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the effect is likely minimal given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| March 1, 2022 | Reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| March 3, 2023 | Reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| March 1, 2024 | One-third of performance stock units vest. |
| August 30, 2024 | Vandervoort exercised performance stock units and restricted stock units. |
| September 3, 2024 | Vandervoort sold 2,817 shares of common stock. |
| September 4, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.